Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralf Bergmann

Showing results (141-150 of 154) with videos related to

Pageof 16
Sort By:
Cancers|October 13, 2021
Targeting Acute Myeloid Leukemia Using the RevCAR Platform: A Programmable, Switchable and Combinatorial StrategyEnrico Kittel-Boselli, Karla Elizabeth González Soto, Liliana Rodrigues Loureiro, et al.
Oncoimmunology|May 17, 2017
A novel nanobody-based target module for retargeting of T lymphocytes to EGFR-expressing cancer cells via the modular UniCAR platformSusann Albert, Claudia Arndt, Anja Feldmann, et al.
Radiation and Environmental Biophysics|January 21, 2015
Comparison study of in vivo dose response to laser-driven versus conventional electron beamMelanie Oppelt, Michael Baumann, Ralf Bergmann, et al.
Oncotarget|February 28, 2018
Retargeting of UniCAR T cells with an <i>in vivo</i> synthesized target module directed against CD19 positive tumor cellsDominik Bachmann, Roberta Aliperta, Ralf Bergmann, et al.
Oncotarget|April 14, 2017
Retargeting of T lymphocytes to PSCA- or PSMA positive prostate cancer cells using the novel modular chimeric antigen receptor platform technology "UniCAR"Anja Feldmann, Claudia Arndt, Ralf Bergmann, et al.
Oncoimmunology|October 25, 2019
A theranostic PSMA ligand for PET imaging and retargeting of T cells expressing the universal chimeric antigen receptor UniCARClaudia Arndt, Anja Feldmann, Stefanie Koristka, et al.
Biosensors & Bioelectronics|March 10, 2022
Nanosensors in clinical development of CAR-T cell immunotherapyTrang Anh Nguyen-Le, Tabea Bartsch, Robert Wodtke, et al.
Oncoimmunology|May 20, 2020
UniCAR T cell immunotherapy enables efficient elimination of radioresistant cancer cellsClaudia Arndt, Liliana R Loureiro, Anja Feldmann, et al.
Cancers|April 23, 2022
Development and Functional Characterization of a Versatile Radio-/Immunotheranostic Tool for Prostate Cancer ManagementClaudia Arndt, Ralf Bergmann, Franziska Striese, et al.
Scientific Reports|February 9, 2020
"UniCAR"-modified off-the-shelf NK-92 cells for targeting of GD2-expressing tumour cellsNicola Mitwasi, Anja Feldmann, Claudia Arndt, et al.
Pageof 16

Showing results (141-150 of 154) with videos related to

Sort By:
Pageof 16
Cancers|October 13, 2021
Targeting Acute Myeloid Leukemia Using the RevCAR Platform: A Programmable, Switchable and Combinatorial StrategyEnrico Kittel-Boselli, Karla Elizabeth González Soto, Liliana Rodrigues Loureiro, et al.
Oncoimmunology|May 17, 2017
A novel nanobody-based target module for retargeting of T lymphocytes to EGFR-expressing cancer cells via the modular UniCAR platformSusann Albert, Claudia Arndt, Anja Feldmann, et al.
Radiation and Environmental Biophysics|January 21, 2015
Comparison study of in vivo dose response to laser-driven versus conventional electron beamMelanie Oppelt, Michael Baumann, Ralf Bergmann, et al.
Oncotarget|February 28, 2018
Retargeting of UniCAR T cells with an <i>in vivo</i> synthesized target module directed against CD19 positive tumor cellsDominik Bachmann, Roberta Aliperta, Ralf Bergmann, et al.
Oncotarget|April 14, 2017
Retargeting of T lymphocytes to PSCA- or PSMA positive prostate cancer cells using the novel modular chimeric antigen receptor platform technology "UniCAR"Anja Feldmann, Claudia Arndt, Ralf Bergmann, et al.
Oncoimmunology|October 25, 2019
A theranostic PSMA ligand for PET imaging and retargeting of T cells expressing the universal chimeric antigen receptor UniCARClaudia Arndt, Anja Feldmann, Stefanie Koristka, et al.
Biosensors & Bioelectronics|March 10, 2022
Nanosensors in clinical development of CAR-T cell immunotherapyTrang Anh Nguyen-Le, Tabea Bartsch, Robert Wodtke, et al.
Oncoimmunology|May 20, 2020
UniCAR T cell immunotherapy enables efficient elimination of radioresistant cancer cellsClaudia Arndt, Liliana R Loureiro, Anja Feldmann, et al.
Cancers|April 23, 2022
Development and Functional Characterization of a Versatile Radio-/Immunotheranostic Tool for Prostate Cancer ManagementClaudia Arndt, Ralf Bergmann, Franziska Striese, et al.
Scientific Reports|February 9, 2020
"UniCAR"-modified off-the-shelf NK-92 cells for targeting of GD2-expressing tumour cellsNicola Mitwasi, Anja Feldmann, Claudia Arndt, et al.
Pageof 16